General Risk Factors and Inflammatory Determinants in Older Patients With Asthma
NCT03278561 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 90
Last updated 2020-08-14
Summary
A cross-sectional study in asthma patients to determine if a late age of onset asthma (start symptoms \>18 years old), is associated with more persistent airway/systemic inflammation, worse asthma control, more co-morbidity, a different microbiome and poorer quality of life despite the use of optimized asthma therapy.
Conditions
- Asthma
- Late-Onset Asthma
- Childhood Asthma
Interventions
- PROCEDURE
-
Sputum induction
Sputum induction according to the ERS protocol
- PROCEDURE
-
Blood sample
A blood sample of 100ml will be taken.
Sponsors & Collaborators
-
Gerdien Tramper
lead OTHER
Principal Investigators
-
GM de Boer, MD · Franciscus Gasthuis Rotterdam
-
GJ Braunstahl, MD, PhD · Franciscus Gasthuis Rotterdam
-
GA Tramper, MD, PhD · Franciscus Gasthuis Rotterdam
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-05-08
- Primary Completion
- 2019-08-31
- Completion
- 2019-12-31
Countries
- Netherlands
Study Locations
More Related Trials
-
The Virtual Asthma Clinic
NCT00562081 ·Status: TERMINATED ·Phase: PHASE4
-
Predictive Ability of Therapeutic Risk Factors in Pediatric and Adult Asthma Patients
NCT01346852 ·Status: COMPLETED
-
Clinico-biological Correlation of Severe Asthma in Children
NCT02038374 ·Status: UNKNOWN ·Phase: NA
-
Comparison Of Molecular Targets In Mild To Severe Asthmatics And Healthy Subjects
NCT00331058 ·Status: TERMINATED ·Phase: PHASE1
-
Symbicort Single Inhaler Therapy for Asthma in a General Practice Setting
NCT00235911 ·Status: COMPLETED ·Phase: PHASE3
-
A 3-week Study Investigating Patient Use and Functionality of Formoterol in a Novel Inhalation Device in Patients With Asthma
NCT00130351 ·Status: COMPLETED ·Phase: PHASE3
-
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
NCT00576069 ·Status: RECRUITING
-
A Cohort Study of Risk Factors and Prognosis for Frequent Acute Asthma Exacerbations Phenotype
NCT06621056 ·Status: RECRUITING
-
Longitudinal Cohort Study in Participants With Severe Asthma to Assess Biomarkers
NCT02537691 ·Status: COMPLETED ·Phase: PHASE4
-
Biomarkers in Exhaled Breath From Asthmatic Patients
NCT00635271 ·Status: TERMINATED
-
Supporting Asthma Management Behaviors in Aging Adults
NCT02316223 ·Status: COMPLETED ·Phase: NA
-
Progression of Airway Obstruction in Childhood Asthma
NCT00873873 ·Status: COMPLETED
-
Assessing Decision Maker Tools for Asthma: the Asthma APGAR
NCT01446315 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of Salmeterol on Brain-Derived Neurotrophic Factor (BDNF) Concentrations in Asthma
NCT00736801 ·Status: COMPLETED ·Phase: NA
-
Individualizing Treatment for Asthma in Primary Care
NCT06272370 ·Status: COMPLETED ·Phase: PHASE4
-
Prospective Study of the Feedback From an Adherence Monitor on Asthma Control
NCT01529697 ·Status: COMPLETED ·Phase: NA
-
Defining the Severe Paediatric Asthma Endotype
NCT04680117 ·Status: COMPLETED ·Phase: NA
-
A Methodology Study To Look At Genes In Lung Cells And Tissue From Asthmatic Patients
NCT00331292 ·Status: TERMINATED
-
Longitudinal Assessment of Children With Severe Asthma and Severe Pre-school Wheeze
NCT01982162 ·Status: COMPLETED
-
Effect of a Pharmaceutical Intervention on the Level of Control of the Asthmatic Patient
NCT01085474 ·Status: COMPLETED
-
Small Airway Inflammation and Dysfunction in Different Asthma Phenotypes
NCT03718793 ·Status: UNKNOWN ·Phase: NA
-
Phenotyping Disease Severity in Asthma
NCT05078021 ·Status: RECRUITING
-
Study in Patients With Asthma
NCT00215358 ·Status: COMPLETED ·Phase: PHASE2
-
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
NCT01225913 ·Status: RECRUITING ·Phase: PHASE4
-
Airflow Obstruction and Biomarkers of Airway Inflammation During and Following Acute Exacerbations of Childhood Asthma
NCT01227070 ·Status: COMPLETED